Cox Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.85M Sell
5,058
-34
-0.7% -$40.1K 3.28% 8
2026
Q2
$6.11M Buy
5,092
+2
+0% +$2.04K 3.4% 6
2026
Q1
$4.68M Buy
5,090
+85
+2% +$86.2K 3.11% 8
2025
Q4
$5.39M Buy
5,005
+22
+0.4% +$21K 3.35% 10
2025
Q3
$3.8M Buy
4,983
+23
+0.5% +$17.1K 2.48% 17
2025
Q2
$3.87M Sell
4,960
-87
-2% -$67.6K 2.64% 14
2025
Q1
$4.17M Buy
5,047
+2,268
+82% +$1.89M 3.04% 13
2024
Q4
$2.15M Sell
2,779
-1,107
-28% -$917K 1.38% 28
2024
Q3
$3.44M Buy
3,886
+2,311
+147% +$2.08M 2.06% 21
2024
Q2
$1.43M Hold
1,575
– – 0.86% 44
2024
Q1
$1.23M Hold
1,575
– – 0.76% 50
2023
Q4
$918K Hold
1,575
– – 0.6% 58
2023
Q3
$846K Sell
1,575
-25
-2% -$12.9K 0.6% 54
2023
Q2
$750K Hold
1,600
– – 0.55% 53
2023
Q1
$549K Sell
1,600
-3
-0.2% -$1.01K 0.4% 59
2022
Q4
$586K Buy
1,603
+3
+0.2% +$1.06K 0.38% 67
2022
Q3
$517K Sell
1,600
-19
-1% -$6.02K 0.38% 60
2022
Q2
$525K Buy
1,619
+19
+1% +$5.7K 0.36% 60
2022
Q1
$458K Hold
1,600
– – 0.29% 67
2021
Q4
$442K Hold
1,600
– – 0.26% 74
2021
Q3
$370K Hold
1,600
– – 0.25% 72
2021
Q2
$367K Hold
1,600
– – 0.25% 73
2021
Q1
$299K Hold
1,600
– – 0.21% 76
2020
Q4
$270K Hold
1,600
– – 0.21% 82
2020
Q3
$237K Hold
1,600
– – 0.21% 75
2020
Q2
$263K Sell
1,600
-140
-8% -$21.5K 0.26% 72
2020
Q1
$229K Hold
1,740
– – 0.2% 71
2019
Q4
$229K Buy
+1,740
New +$202K 0.21% 70
2019
Q2
– Sell
-1,600
Closed -$208K – 70
2019
Q1
$208K Buy
+1,600
New +$195K 0.22% 67

Other funds holding LLY

Cox Capital Management's LLY Position: Q3 2026 in Review

Cox Capital Management reduced its Eli Lilly (LLY) stake by 0.67% in Q3 2026, selling an estimated $40.1K and leaving 5,058 shares worth $5.85M. The position accounts for 3.28% of the portfolio, ranked #8.

Cox Capital Management first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $6.11M in Q2 2026. 2,057 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cox Capital Management held 5,058 shares of Eli Lilly worth $5.85M as of Q3 2026.
  • Cox Capital Management sold 34 Eli Lilly shares in Q3 2026, an estimated $40.1K.
  • Eli Lilly made up 3.28% of Cox Capital Management's portfolio in Q3 2026, its #8 holding.
  • Cox Capital Management first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Cox Capital Management's Eli Lilly position peaked at $6.11M in Q2 2026.
  • 2,057 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cox Capital Management's 13F filing for Q3 2026, filed 7 Oct 2026.